Objective 1.To find out the optimal number of examined lymph nodes(ELNs)in stage IA non-small cell lung cancer(NSCLC).2.To figure out whether there was a turning point beyond which ELNs might have adv
Objective Pulmonary blastoma(PB)is a rare malignant neoplasm that account for a small percentage of non-small-cell lung cancer(NSCLC).Due to its rarity,little is known about this disease,we sought to